These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12412374)

  • 1. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
    Valeri A; Drelon E; Paiss T; Vogel W; de Petriconi R; Hautmann R; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):680-8. PubMed ID: 10555221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
    Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
    Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a prostate cancer susceptibility locus on the X chromosome.
    Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
    Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
    Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
    Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
    Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
    Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
    Elkins DA; Yokomizo A; Thibodeau SN; J Schaid D; Cunningham JM; Marks A; Christensen E; McDonnell SK; Slager S; J Peterson B; J Jacobsen S; R Cerhan J; L Blute M; J Tindall D; Liu W
    Prostate; 2003 Jun; 56(1):30-6. PubMed ID: 12746844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
    Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
    Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
    Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex genetic epidemiology of prostate cancer.
    Schaid DJ
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
    Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
    Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
    Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
    Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
    Valeri A; Berthon P; Fournier G; Buzzi JC; Briollais L; Meria P; Blanche H; Bellanne-Chantelot C; Teillac P; Demenais F; Mangin P; Cohen N; Le Duc A; Cussenot O
    Prog Urol; 1996 Apr; 6(2):226-35. PubMed ID: 8777415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
    Xu J; Gillanders EM; Isaacs SD; Chang BL; Wiley KE; Zheng SL; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Meyers DA; Walsh PC; Trent JM; Isaacs WB
    Prostate; 2003 Dec; 57(4):320-5. PubMed ID: 14601028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.